Page last updated: 2024-09-05

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Anasarca

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with Anasarca in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, RA; Cummings, J; Haslett, C; MacKinnon, AC; Sethi, T; Smyth, JF; Waters, CM1

Other Studies

1 other study(ies) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Anasarca

ArticleYear
[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
    British journal of cancer, 1999, Volume: 80, Issue:7

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Edema; Enzyme Activation; GTP-Binding Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mice; Mitogen-Activated Protein Kinases; Neuropeptides; Oligopeptides; Rabbits; Reactive Oxygen Species; Tumor Cells, Cultured

1999